Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 May 9;23(8):1521–1528. doi: 10.1158/1055-9965.EPI-13-1176

Table 3. Independent effects of test preference, test access, and navigation on CRC screening adherence (N = 933*).

Overall screening FIT screening vs. none CX screening vs. none
OR (95% CI) p OR (95% CI) p OR (95% CI) p
Test preference 0.940 0.005 0.032
 FIT 1.02 (0.61, 1.71) 0.930 1.33 (0.70, 2.53) 0.384 0.59 (0.25, 1.39) 0.226
 Equal FIT/CX 1.00 Ref 1.00 Ref 1.00 Ref
 CX 0.94 (0.60, 1.46) 0.787 0.44 (0.23, 0.84) 0.013 1.61 (0.93, 2.81) 0.091

Test access
 Usual care 1.00 Ref 1.00 Ref 1.00 Ref
 Mailed FIT kit + CX number 2.64 (1.79, 3.90) 0.001 29.1 (10.3, 82.0) 0.001 0.71 (0.42, 1.19) 0.194

Navigation
 No navigation 1.00 Ref 1.00 Ref 1.00 Ref
 Navigation FIT + CX 2.09 (1.26, 3.49) 0.005 1.53 (0.85, 2.76) 0.157 3.22 (1.52, 6.82) 0.002
*

Final multivariable results based on 933 participants with full covariate data. The model included the three variables shown in the table, and controlled for primary care practice, age, sex, race, education, marital status, perceptions of CRC and screening, and baseline screening decision stage

FIT: fecal immunochemical test. CX: colonoscopy.